EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Global Estimates of Vaccine-Associated Hepatic Autoimmune Disorders and Their Related Vaccines, 1968–2024: An International Analysis of the WHO Pharmacovigilance Database

Jinyoung Jeong, Hyesu Jo, Jaeyu Park, Lee Smith, Masoud Rahmati, Kwanjoo Lee, Yeonjung Ha, Dong Keon Yon

International Archives of Allergy and Immunology · 2024-12-02 · 186 (7) · 696-702

DOI: 10.1159/000542865 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Previous studies have suggested an association between vaccines and autoimmune diseases, but they were limited by their narrow focus and timeframe. Methods: This study conducted the first large-scale international analysis to investigate the impact of various vaccines on autoimmune liver diseases. Utilizing WHO’s VigiBase data from 1968 to 2024, and the study identified 1,083 (0.012%) cases of vaccine-associated hepatic autoimmune disorders out of 8,562,584 reported vaccine adverse events. Results: The vaccines with the highest risk of hepatic autoimmune disorders were the hepatitis B vaccine (reporting odds ratio [ROR], 3.52; 95% CI, 2.50–4.95), COVID-19 mRNA vaccines (ROR, 2.95; 95% CI, 2.73–3.18), and papillomavirus vaccines (ROR, 2.13; 95% CI, 1.45–3.13). Additionally, when vaccine-associated hepatic autoimmune disorders occurred, hepatobiliary adverse events were frequently observed to occur concurrently. Conclusions: This study suggests that vaccines may induce hepatic autoimmune disorders and highlights the need for enhanced monitoring before and after vaccination. Additionally, it proposes implementing pre-vaccination screening protocols and postvaccination monitoring to address this concern.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →